Breaking News

Mink Therapeutics Inc (INKT)

NASDAQ

Add to/Remove from a Portfolio Add to Watchlist

14.9100 -0.4100 -2.68%

15/08 - Closed. Currency in USD

Pre Market

15.5000

+0.5900

+3.9571%

10:10:06 - Real-time Data

Type: Equity

Market: United States

Volume: 189,209
Bid/Ask: 0.0000 / 0.0000
Day's Range: 14.9100 - 18.1688

General
Chart
- Streaming charts
- Interactive Chart
News & Analysis
- News
- Analysis & Comment
Financials
Technical
Forum

Mink Therapeutics Inc Company Profile

Get an in-depth profile of Mink Therapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.

IndustryBiotechnology & Medical Research

SectorHealthcare

Employees

Equity Type

ORD

MiNK Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, manufacture, and commercialization of allogeneic, off-the-shelf, and invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company develops agenT-797, an off-the-shelf, allogeneic, and native iNKT cell therapy that is in Phase 2 clinical trial for the clinical safety and efficacy of the combination of agenT-797, botensilimab plus balstilimab with ramucirumab and paclitaxel for patients with previously treated, advanced esophageal, gastric, or gastro-esophageal junction adenocarcinoma; Phase 1 trial as a monotherapy in combination with anti-PD-1 checkpoint inhibitors, pembrolizumab, and nivolumab for refractory solid tumor cancers; and Phase 1 trial for the treatment of moderate to severe viral acute respiratory distress syndrome. It is also developing MiNK-215, an IL-15 armored tumor stromal targeting the FAP-CAR-iNKT program to treat solid tumors and inflammation; and MiNK-413, an IL-15 armored CAR-iNKT program targeting B cell maturation antigen for auto-immune diseases. The company has collaborations with Autonomous Therapeutics to target and treat metastatic tumors; and ImmunoScape, Inc. to discover and develop T-cell receptor therapies against targets in solid tumors. The company was formerly known as AgenTus Therapeutics, Inc. and changed its name to MiNK Therapeutics, Inc. in June 2021. The company was incorporated in 2017 and is based in New York, New York. MiNK Therapeutics, Inc. operates as a subsidiary of Agenus Inc.

Contact Information

Address 149 Fifth Avenue Suite 500
New York, 10010
United States

Phone 212 994 8250

Fax -

Web minktherapeutics.com

Top Executives

Name	Age	Since	Title
Garo H. Armen	69	2017	Executive Chairman
Jennifer Buell	46	2021	President, CEO & Director
Manuel Hidalgo	56	-	Member of the Scientific Advisory Board
Marcela V. Maus	47	-	Member of the Scientific Advisory Board
Yekaterina Chudnovsky	39	2024	Board Observer
Robert Benjamin Stein	73	-	Member of the Scientific Advisory Board
Ulf Arne Wiinberg	66	2017	Independent Director
Lydia Lynch	-	-	Member of the Scientific Advisory Board
Mark A. Exley	-	-	Member of the Scientific Advisory Board
Barbara A. Ryan	64	2021	Independent Director
Peter Behner	60	2021	Independent Director
Brian J. Corvese	66	2017	Independent Director
Robert Kadlec	67	2024	Independent Director

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com Nigeria's comment guidelines and agree to the terms described.

I Agree

INKT Comments

Write your thoughts about Mink Therapeutics Inc

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d72-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d72-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d72-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

NSE 30	5,282.51	+0.24	+0.00%
NSE All Share	144,820.90	+192.70	+0.13%
US 30	44,907.0	-39.1	-0.09%
US 500	6,444.6	-5.2	-0.08%
FTSE 100	9,132.35	-6.55	-0.07%
DAX	24,276.04	-98.83	-0.41%
South Africa Top 40	93,713.60	-784.78	-0.83%

Brent Oil	66.07	+0.22	+0.33%
Crude Oil WTI	62.27	+0.29	+0.47%
Gold	3,394.15	+11.55	+0.34%
Silver	38.170	+0.195	+0.51%
Copper	4.4688	-0.0237	-0.53%
London Cocoa	5,604.00	+17.00	+0.30%
London Wheat	167.00	-2.40	-1.42%

Nigeria 10Y	15.677	+0.000	+0.00%
Nigeria 2Y	16.823	+0.000	+0.00%
U.K. 10Y	4.6830	-0.0130	-0.28%
Germany 10Y	2.7567	-0.0233	-0.84%
U.S. 10Y	4.293	-0.034	-0.79%
U.S. 5Y	3.817	-0.028	-0.73%
U.S. 2Y	3.740	-0.019	-0.51%

Fidelitybk	20.800	-0.150	-0.72%
Zenith Bank	72.35	-0.05	-0.07%
UBA	48.30	+0.30	+0.62%
First HoldCo	32.95	+0.10	+0.30%
Guaranty Trust Holding	97.35	-0.35	-0.36%
Sterling Bank	8.000	+0.500	+6.67%
Dangote Cement	526.00	-51.00	-8.84%

Recent Quotes

Name	Price	Chg.	Chg. %
INKT	14.9100	-0.4100	-2.68%
Mediolanum Previg.	20.678	+0.309	+1.52%
Yellow Funds SICA.	95.170	-0.070	-0.07%
GXYp	0.08	0.00	0.00%
GIIXU	10.06	0.00	0.00%
Pioneer Funds - E.	1,529.930	+0.040	+0.00%
Morgan Stanley In.	20.770	-0.010	-0.05%
Desjardins Global.	13.877	0.000	0.00%

Market Movers

Name	Last	Chg. %	Vol.
Lasaco Assurance PLC	4.00	-1.23%	46.93M
Mutual Benefits Assurance	4.23	+9.87%	46.41M
Access Holdings	27.40	-1.97%	13.42M
Zenith Bank	72.35	-0.07%	3.85M
ETI	39.60	+2.06%	3.82M
Aradel Holdings	512.00	-1.35%	1.20M
Dangote Cement	526.00	-8.84%	326.13K

Name	Last	Chg. %	Vol.
UPDC	7.15	+10.00%	2.91M
Airtel Africa	2,541.50	+10.00%	5.00
Aiico	4.18	+10.00%	24.34M
SCOA Nigeria	6.050	+10.00%	2.16K
Cornerst	7.60	+9.99%	4.06M
Coronation Insurance	3.99	+9.92%	8.58M
International Energy Insurance	3.66	+9.91%	5.98M

Name	Last	Chg. %	Vol.
Geregu Power	1,027.40	-10.00%	2.31K
BUA Foods	529.20	-10.00%	22.38K
Guinness Nigeria	140.20	-9.98%	12.37K
Conoil	211.10	-9.98%	9.35K
BUA Cement	151.80	-9.96%	486.98K
Transcorp Power	260.00	-9.25%	99.22K
Dangote Cement	526.00	-8.84%	326.13K